patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
dexmedetomidine
Marketedupdated 2mo agoby $BTAI BioXcel Therapeutics, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for irritability and 84 investigational indications.
indications
investigational
Schizophrenia
targets
Adrenergic receptor alpha-2
all catalysts(18)
approval · 3
phase 0 trial completion · 7
phase 2 3 completion · 1
phase 2 completion · 6
phase 2 initiation · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that